TABLE 1

LC/MS/MS analytical methods


Catalytic Activity

P450-Selective Activity

IS

Sample Preparationa

Column and Flow Rate

Mobile Phases

Gradient Conditions

Ionization Mode

Ions Monitored (m/z)
R-95913→R-138727 Not applicable 2H4-R-138727 A Monochrome C18, 5 μm, 100 × 2.0 mm (Metachem); 0.2 ml/min A: 5% methanol in 0.2% formic acid; B: 95% methanol in 0.2% formic acid 6 min: escalation from 10% B to 95% B and back to 10% B Positive electrospray 498→348 for derivatized R-138727; 502→111 for derivatized IS
Phenacetin→acetaminophen CYP1A2 2H4-acetaminophen B Monochrome C18, 5 μm, 50 × 2.0 mm (Metachem); 0.2 ml/min A: 5% methanol in 5 mM ammonium acetate; B: 95% methanol in 5 mM ammonium acetate 3.6 min: escalation from 10% B to 80% B and back to 10% B Positive electrospray 152→110 for acetaminophen; 155.95→114.05 for IS
S-Mephenytoin→4′-hydroxy S-mephenytoin CYP2C19 phenytoin B Monochrome C18, 5 μm, 50 × 2.0 mm (Metachem); 0.2 ml/min A: 5% methanol in 5 mM ammonium acetate; B: 95% methanol in 5 mM ammonium acetate 3.6 min: escalation from 10% B to 80% B and back to 10% B Negative electrospray 233→189.9 for 4′-hydroxy S-mephenytoin; 250.9→102.1 for IS
Midazolam→1′-hydroxy-midazolam
CYP3A
α-hydroxy-triazolam
C
YMC-AQ, C18, 5 μm, 100 × 2.0 mm (Waters); 0.22 ml/min
A: 5% methanol in 50 mM ammonium acetate; B: 95% methanol in 50 mM ammonium acetate
6.0 min: escalation from 65% B to 95% B and back to 65% B
Positive electrospray
342→324 for 1′-hydroxy-midazolam; 359→331 for IS
  • a Sample Preparation Methods: A, internal standard (IS) and 10 mM BMAP (derivatizing agent) added in an equal volume of acetonitrile (ACN) to stop reactions; samples centrifuged and 30-μl supernatant diluted with 170 μl of deionized water. B, IS added in an equal volume of ACN to stop reactions; samples centrifuged and 30-μl supernatant diluted with 170 μl of deionized water. C, equal volume of ACN added to stop reactions; IS (20 μl) added, samples centrifuged, and 30-μl supernatant diluted with 170 μl of deionized water.